31
Participants
Start Date
December 31, 2013
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
Intravenous hyperimmune immunoglobulin (Flu-IVIG)
Placebo
Montefiore Medical Center, The Bronx
George Washington University, Washington D.C.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
Ohio State University Wexner Medical Center, Columbus
Miami Valley Hospital, Dayton
Henry Ford Hospital, Detroit
Mayo Clinic, Rochester
University of Texas Southwestern Medical Center, Dallas
Denver Public Health, Denver
University of California at San Diego, San Diego
Cooper University Hospital, Camden
National Institute of Allergy and Infectious Diseases (NIAID)
NIH